Education
About Us
Working with TipRanks
Follow Us
Xoma Corp (XOMA)
NASDAQ:XOMA
XOMA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$18.35 - $35.00
Previous CloseN/A
Volume8.24K
Average Volume (3M)27.55K
Market Cap
$253.16M
Enterprise Value$324.15M
Total Cash (Recent Filing)$28.42M
Total Debt (Recent Filing)$13.34M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
May 13, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.06
Shares Outstanding11,952,889
10 Day Avg. Volume21,911
30 Day Avg. Volume27,553
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.78
Price to Cash Flow (P/CF)-21.50
P/FCF Ratio0.00
Enterprise Value/Market Cap1.28
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.46
Enterprise Value/Ebitda-11.67
Forecast
1Y Price Target
$64.67Price Target Upside205.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Xoma News
PremiumCompany Announcements
XOMA Royalty Reports Strong 2024 Financial Growth
PremiumPre-Earnings
Is XOMA a Buy, Before Earnings?---
Bulls Say, Bears Say
Bulls Say
Clinical ProgressInvestors in XOMA can look forward to clinical progress from several of the Company’s 10 products in Phase 3 trials, with data announcements expected from key trials.
Financial StrengthXOMA ended the year financially strong with $106.8 million in cash, balanced by growing revenues from royalties and milestones.
Portfolio ExpansionXOMA has expanded its commercial asset portfolio to six products recently, through acquisitions and internal growth, which is expected to boost revenues by over 20% annually.
Bears Say
Revenue ChallengesXOMA reported 4Q24 total revenue of $8.7M, 19% above the analyst estimate, but the shares have risen 50% from lows in 2023, yet valuation challenges remain.
Valuation ConcernsDespite a strong recovery from post-COVID-19 lows, XOMA's valuation still lags behind comparable companies, offering potential for rerating higher based on strong fundamentals and expanding visibility.
---
Ownership Overview
1.12% Insiders
13.48% Mutual Funds
39.46% Other Institutional Investors
39.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
XOMA FAQ
What was Xoma Corp’s price range in the past 12 months?
Xoma Corp lowest stock price was $18.35 and its highest was $35.00 in the past 12 months.
What is Xoma Corp’s market cap?
Xoma Corp’s market cap is $253.16M.
When is Xoma Corp’s upcoming earnings report date?
Xoma Corp’s upcoming earnings report date is May 13, 2025 which is in 24 days.
How were Xoma Corp’s earnings last quarter?
Xoma Corp released its earnings results on Mar 17, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.287 by $0.247.
Is Xoma Corp overvalued?
According to Wall Street analysts Xoma Corp’s price is currently Undervalued.
Does Xoma Corp pay dividends?
Xoma Corp does not currently pay dividends.
What is Xoma Corp’s EPS estimate?
Xoma Corp’s EPS estimate is -0.24.
How many shares outstanding does Xoma Corp have?
Xoma Corp has 11,952,889 shares outstanding.
What happened to Xoma Corp’s price movement after its last earnings report?
Xoma Corp reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.287. Following the earnings report the stock price went up 0.772%.
Which hedge fund is a major shareholder of Xoma Corp?
Currently, no hedge funds are holding shares in XOMA
---
Xoma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$64.67 (205.34% Upside)
$64.67 (205.34% Upside)
Hedge Fund Trend
Increased
By 60.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $16.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.65%
12-Months-Change
Fundamentals
Return on Equity
-16.20%
Trailing 12-Months
Asset Growth
-3.13%
Trailing 12-Months
Company Description
Xoma Corp
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
---
XOMA Stock 12 Month Forecast
Average Price Target
$64.67
▲(205.34% Upside)
Technical Analysis
Best Analysts Covering XOMA
1 Year
1 Year Success Rate
6/17 ratings generated profit
1 Year Average Return
+1.15%
reiterated a buy rating 24 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 35.29% of your transactions generating a profit, with an average return of +1.15% per trade.
---